In 2019, an Iraqi Ministry of Health (MOH) report found that around 60-70% of medicines in the private sector do not enter the country through official processes (they are neither registered nor quality tested) – a problem that arose in Iraq after 2003, when the importation of medicines to the private sector became decentralised.
Substandard and falsified medications impact the world especially low and middle-income countries, and the problem in Iraq arose in 2003, especially after the importation of medicines to the private sector became decentralised.
Read more about it here: https://www.uppsalareports.org/articles/substandard-and-falsified-medications-in-iraq-s-private-sector/
